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MMP-7 IN THE DEVELOPMENT OF ENDOTHELIAL DYSFUNCTION AND 
ATHEROSCLEROSIS 
 
Yu Cai, Yan Liang, Mary YK Lee, Paul M Vanhoutte and Yu Wang 
Pharmacology and Pharmacy, University of Hong Kong, China 
 
Matrix metalloproteinase (MMP)-7, also called matrilysin, belongs to MMPs family of 
proteolytic enzymes that cleaves matrix components such as fibronectin, gelatins, collagen, 
laminin, entactinnidogen, and elastin. Alterations in the regulation of MMP-7 activity are 
implicated in diseases such as cancer, fibrosis, arthritis and atherosclerosis. Functional 
polymorphisms in MMP7 gene have been related to coronary artery disease, such as arterial 
stiffness and atherosclerotic plaque formation. However, the pathophysiological role of MMP-7 
in the development of cardiovascular disease has not been fully characterized. Previous 
microarray experiments reveal that the gene expression of MMP7 is highly upregulated in 
regenerated endothelial cells of the porcine coronary artery after balloon injury. Cholesterol diet 
feeding partially prevents the upregulation of MMP7 in regenerated endothelial cells. In the 
present study, the endothelial function and the development of atherosclerosis in ApoE knockout 
(ApoE-/-) mice was monitored and compared with those of MMP7 deficient ApoE-/- mice. The 
results demonstrate a double-edged role of MMP7 in the development of endothelial dysfunction 
and atherosclerosis. 
